A 67-year-old Caucasian man presented with atrial flutter on routine 12-lead electrocardiography (ECG). Following appropriate anticoagulation, he successfully underwent atrial flutter ablation. Echocardiography during the admission showed concentric left ventricular (LV) hypertrophy with severely impaired LV systolic function, particularly longitudinal ( Figure 1A, video 1) , and biatrial dilatation. Due to episodes of non-sustained ventricular tachycardia, he was fitted with an implantable cardioverter-defibrillator (ICD).
The ECG QRS complexes on peripheral leads were small compared to the structural wall thickening on echocardiography ( Figure 1B ) raising the suspicion of cardiac amyloidosis.
Preliminary evaluation excluded a plasma cell dyscrasia (negative serum free light chains changes and urinary Bence-Jones protein). Serum amyloid P component (SAP) scintigraphy was negative for visceral organ uptake and bone tracer scintigraphy (Technetium-DPD) was positive with Perugini Grade 2-3 uptake ( Figure 1C ), consistent with a diagnosis of cardiac transthyretin amyloidosis (ATTR). Cardiac magnetic resonance (CMR) was contra-indicated due to the non-conditional ICD ( Figure 1D ). After giving fully informed written consent, cardiac computed tomography (CCT) was performed as part of a research study, using a three step protocol ( Figure 1E ) as previously described 1 , allowing calculation of the extracellular volume fraction (ECV) from pre-and 5-minutes post-contrast images. The septal ECV, calculated from a co-registered, segmented myocardial mask displaying pixel-by-pixel ECV values, was in the amyloid spectrum elevated at 63% (Figure 1F ), Gene sequencing revealed a heterozygous V122I mutation, confirming the diagnosis of familial amyloid cardiomyopathy (ATTR).
Discussion
Quantification of the myocardial ECV using two-phase cardiac CT can discriminate between cardiac amyloidosis and other disease with myocardial hypertrophy. The ECV by CMR and CT strongly correlated, making CCT a valid alternative to CMR 1 , which itself is known to have good sensitivity and specificity for the diagnosis, prognostication and monitoring of cardiac amyloidosis 2 . Here, CCT added value as there was a MR non-conditional ICD in-situ. 
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